All News

obesity.knee_.arthritis.jpg

Triple Hormone Receptor Agonist for Treatment of Obesity and Knee Osteoarthritis

Jack Cush, MD

The NEJJM reports that Retatrutide, an investigational incretin agent, was shown to

Read Article
RheumNow Podcast square

Remission – Believe it or Not (10.2.2026)

Jack Cush, MD

Dr, Jack Cush reviews the news and journal articles from the past week on RheumNow.com

Read Article
SLE.Pearl

Petri SLE Pearls: An Update

Kathryn H. Dao, M.D.

At the CCR West 2026 conference in Huntington Beach, California, Dr. Michelle Petri updated her Petri Pearls. Some are derived from new data, while others are from her extensive experience caring for patients with systemic lupus erythematosus (SLE).

Read Article
phys.therapy.knee2_.jpg

Supervised Physiotherapy Wins after ACL Repair

Jack Cush, MD

The Annals of Internal Medicine has shown that chronic knee symptoms following anterior cruciate ligament reconstruction (ACLR) surgery is significantly lessened by a program of physiotherapist-supervised exercise therapy with education compared to single education and self-directed exer

Read Article
obesity,scale,weight

Link Between Obesity and Psoriatic Arthritis

Jack Cush, MD

Obesity is an incidental comorbidity in psoriatic arthritis (PsA). It is a modifiable, mechanistically active driver of disease onset, severity, and treatment failure. A new comprehensive review in RMD Open (Madsen et al., 2026) synthesizes 49 studies suggesting that weight management belongs in the core PsA treatment algorithm.

Read Article
steroid prednisone lab

Prednisone Primer for Patients

Jack Cush, MD

The Washington Post published a patient overview on "what Prednisone does to your body".

Read Article
diet,greek,mediterranean,salad

Mediterranean Diet Lowers Incident Rheumatoid Arthritis Risk

Jack Cush, MD

The American Journal of Clinical Nutrition has published the results of the SUN Project study, showing that long-term adherence to a Mediterranean diet (MedDiet) was associated with a substantially lower risk of incident rheumatoid arthritis (RA), but not psoriasis. 

Read Article
woman,doctor

Bringing TOGETHER-PsA Into Clinical Practice

Eric Dein, MD

When Ms. RS came into my clinic for a new patient evaluation, she was suffering from highly active skin disease, joint swelling, pain and poor mobility. Her body mass index was 46, indicating class III obesity. A treatment plan focused solely on her inflammatory disease without addressing her weight would not fully address her overall disease burden.

Read Article
RheumNow Podcast square

Rheumatology Pay Up (9.25.2026)

Jack Cush, MD

Dr. Jack Cush reviews the news and journal reports from this past week on RheumNow.com.

Read Article
pills-14550__180_0.jpg

Gabapentin Use Rose as Restrictions Fell, Study Shows

MedPage Today

Gabapentin use jumped quickly in Michigan after the drug was removed from the state's controlled substance schedule in 2024, a cross-sectional study showed.

Read Article
Supervised Physiotherapy Wins after ACL Repair The Annals of Internal Medicine has shown that chronic knee symptoms following anterior cruciate ligament reconstruction (ACLR) surgery is significantly lessened by a program of physiotherapist-supervised exercise therapy with https://t.co/8HWmkmIexr
Dr. John Cush RheumNow ( View Tweet)
Prednisone Primer for Patients The Washington Post published a patient overview on "what Prednisone does to your body". Prednisone is a double-edged drug. It has been on the market since 1955, ranks among the 40 most-prescribed US drugs, and about 10 million Americans receive

Dr. John Cush RheumNow ( View Tweet)

VA/DoD 2025 Obesity Guidelines Annals of Internal Medicine has published the updated 2025 U.S. Department of Veterans Affairs and U.S. Department of Defense Clinical Practice Guidelines on adult Overweight and Obesity management. This effort involved a multidisciplinary panel https://t.co/ukuKGCHhOf
Dr. John Cush RheumNow ( View Tweet)
RHEUM Survey>> Should rheumatologists run dedicated obesity clinics? Answer here>> https://t.co/O1DEKQLnYg

Links:

Dr. John Cush RheumNow ( View Tweet)

Gabapentin Use Rose as Restrictions Fell, Study Shows Gabapentin use jumped quickly in Michigan after the drug was removed from the state's controlled substance schedule in 2024, a cross-sectional study showed. https://t.co/xQ9MHqnNxB https://t.co/ipOWS4K61U

Links:

Dr. John Cush RheumNow ( View Tweet)
🚨 Registration opens October 1! RheumNow Live 2027 returns January 30–31 for our 9th Annual CME Meeting. 📍 Dallas + Online 📅 January 30–31, 2027 🎓 High-impact CME. Expert faculty. Real-world rheumatology. The rheumatology meeting that sets the tone for the year ahead. https://t.co/1u27pab4Ee
Dr. John Cush RheumNow ( View Tweet)
It’s almost time. 🔥 Registration for RheumNow Live 2027 opens OCTOBER 1. Two days of practical, engaging rheumatology education designed to challenge how you think and influence how you practice. 📅 Jan 30–31, 2027 📍 Dallas + Online https://t.co/Ju0zzYX8Tl
Dr. John Cush RheumNow ( View Tweet)
New report shows Median total cash compensation increased across all seven specialty groups in 2026; adult medical rose 7.2% - Rheumatology led one-year pay growth at 10.4% https://t.co/iuonfJRsf6 https://t.co/zybCZeNV5I

Links:

Dr. John Cush RheumNow ( View Tweet)
Early RA Referral Clinics Work (9.18.2026) Dr. Jack Cush reviews the news and journal reports from this past week on https://t.co/ofGKCCNQnE https://t.co/fn0L4goAMT https://t.co/F8QKs7261x

Links:

Dr. John Cush RheumNow ( View Tweet)
🚨 Registration opens October 1! RheumNow Live 2027 returns January 30–31 for our 9th Annual CME Meeting. 📍 Dallas + Online 📅 January 30–31, 2027 🎓 High-impact CME. Expert faculty. Real-world rheumatology. The rheumatology meeting that sets the tone for the year ahead. https://t.co/PFZ37DlTQe
Dr. John Cush RheumNow ( View Tweet)
How well do you know this week's rheumatology news?
Take the rheumIQ quiz
Take the RheumIQ Quiz

×